Peptide vaccination in Montanide adjuvant induces and GM-CSF increases CXCR3 and cutaneous lymphocyte antigen expression by tumor antigen-specific CD8 T cells

Cancer immunology research

Volumn 1, Issue 5, 2013, Pages 332-339

  Clancy Thompson, Eleanor ^a   King, Laura K ^a   Nunnley, Lenora D ^a   Mullins, Irene M ^a   Slingluff, Craig L ^a   Mullins, David W ^a  

^a DARTMOUTH MEDICAL SCHOOL   (United States)

Author keywords

adjuvant; CLA; CXCR3; GM CSF; IL 12R; melanoma; peptide vaccines

Indexed keywords

CANCER VACCINE; CHEMOKINE RECEPTOR CXCR3; CXCR3 PROTEIN, HUMAN; GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR; MANNITOL; MONTANIDE ISA 51; OLEIC ACID; PEPTIDE; TUMOR ANTIGEN; TUMOR PROTEIN;

AMINO ACID SEQUENCE; ANALOGS AND DERIVATIVES; BIOSYNTHESIS; CD8+ T LYMPHOCYTE; CLINICAL TRIAL; HUMAN; IMMUNOLOGY; MELANOMA; MOLECULAR GENETICS; PHASE 2 CLINICAL TRIAL;

AMINO ACID SEQUENCE; ANTIGENS, NEOPLASM; CANCER VACCINES; CD8-POSITIVE T-LYMPHOCYTES; GRANULOCYTE-MACROPHAGE COLONY-STIMULATING FACTOR; HUMANS; MANNITOL; MELANOMA; MOLECULAR SEQUENCE DATA; NEOPLASM PROTEINS; OLEIC ACIDS; PEPTIDES; RECEPTORS, CXCR3;

EID: 84922584615     PISSN: None     EISSN: 23266074     Source Type: Journal    
DOI: 10.1158/2326-6066.CIR-13-0084     Document Type: Article

References (0)